Paydirt
Insider filing · TVTX

Christopher R. Cline sold $700K of Travere Therapeutics (TVTX)

Executed Dec 1 2025, disclosed Dec 3 2025, 2 days later.

Value, as filed
$700K
20,000 sh × $35.01
Executed
Dec 1 2025
the trade date, as filed
Disclosed
Dec 3 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
CC Christopher R. Cline CHIEF FINANCIAL OFFICER profile →

Christopher R. Cline (CHIEF FINANCIAL OFFICER) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $3.1M of TVTX (50,108 sh across 3 lots, as filed), executed Sep 15.

The name
TVTX Travere Therapeutics, Inc. TVTX · Healthcare · 73 filings in 24 months ticker →

Healthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Christopher R. Cline in TVTX
TVTXSALE Travere Therapeutics, Inc. $3.1M
50,108 sh across 3 lots
Exec Sep 15
Filed Sep 17 · 9:30 PM ET TVTXSALE Travere Therapeutics, Inc. $102K
2,181 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $304K
7,239 sh × $41.93
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $233K
7,242 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $104K
5,192 sh × $20.12
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET